Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
A double-blind, placebo-controlled Phase I trial in 24 healthy volunteers and 24 patients with coronary artery disease (CAD) showed that single doses of 5-40 mg/kg IV MDCO-216 were well tolerated with...